← Back to Search

Device

Fistula Cannula for Chronic Kidney Failure

N/A
Waitlist Available
Research Sponsored by Medtronic - MITG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to verify if the Argyle™ Safety Fistula Cannula with Anti-reflux Valve is safe and effective for use during hemodialysis treatment.

Who is the study for?
This trial is for adults over 18 who are undergoing in-center hemodialysis and have a mature arteriovenous fistulae (AVF) as per clinical standards. Participants must consent to the study's procedures.
What is being tested?
The Argyle Safety Fistula Cannula with Anti-reflux Valve, designed for safer and more effective hemodialysis treatment, is being tested for its safety and performance.
What are the potential side effects?
While specific side effects aren't listed, they may include discomfort at the cannulation site, potential infection risks, or issues related to dialysis access.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Successful Hemodialysis Sessions
Secondary study objectives
Access-related complications requiring procedural intervention
Cannulation Locations with securement details
Cannulator Satisfaction Questionnaire
+5 more
Other study objectives
Summary of Needle Stick Injury within past 6 months from start of study by investigational site
Time to successful cannulation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Argyle Fistula Cannula SubjectsExperimental Treatment1 Intervention
All subjects enrolled in the study and treated with the Argyle Safety Fistula Cannula with Anti-reflux Valve

Find a Location

Who is running the clinical trial?

Medtronic - MITGLead Sponsor
263 Previous Clinical Trials
300,848 Total Patients Enrolled
1 Trials studying Kidney Failure
15 Patients Enrolled for Kidney Failure
~23 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top